Stem Cell Therapy at Klara Medical Center in Częstochowa, Poland

Klara Medical Center in Częstochowa provides specialized cell-based treatments utilizing mesenchymal stem cells (MSCs) harvested from sources such as umbilical cord tissue (Wharton’s Jelly). Administered strictly within the framework of an official therapeutic medical experiment, these regimens are designed to address targeted ophthalmological and neurological conditions. Entry into the experimental program requires a formal medical qualification assessment led by Dr. Beata Świątkowska-Flis, a specialist in adult neurology. During this intake consultation, Dr. Świątkowska-Flis examines the patient's current health status, reviews prior medical records, and verifies that all eligibility requirements for the experimental treatment are met. Key treatment logistics, including the delivery method, appointment length, and post-infusion monitoring protocols, are individually tailored and finalized directly with the patient throughout this screening process. Klara Medical Center offers cell-based therapeutic programs for adults with a range of neurological disorders. The adult program covers spinocerebellar ataxia, muscular dystrophies, spastic quadriplegia, spinal muscular atrophy (SMA) type 1, multiple sclerosis, amyotrophic lateral sclerosis (ALS), severe developmental disorders, and motor neuron disease. Within adult ophthalmology, cell-based treatment programs are available for selected optic disorders, including optic neuropathies and optic nerve atrophy. The adult therapeutic project is generally intended for patients aged 18 to 85, while a separate pediatric project covers children aged 1 to 18. Women of childbearing potential are required to use contraception during the treatment program. Patients are not eligible when they have an active infection, severe disease affecting major organs, are pregnant or breastfeeding, or have a malignant cancer. The final decision regarding eligibility for stem cell therapy is made individually by the physician responsible for supervising the therapeutic project, following a review of the patient's medical condition and documentation. Klara Medical Center also runs a dedicated cell-based therapeutic project for pediatric patients. This program is conducted as part of a therapeutic medical experiment and is evaluated separately from the adult program. The pediatric cell-based therapy project covers conditions including cerebral palsy, Huntington's disease, drug-resistant epilepsy, encephalopathy, cerebellar ataxia, pervasive developmental disorders, spina bifida, multiple sclerosis, and muscular dystrophy. Each child is assessed individually for participation. Qualification is determined based on the child's available medical records and a clinical evaluation.